Literature DB >> 21411573

Transfer of KPC-2 Carbapenemase from Klebsiella pneumoniae to Escherichia coli in a patient: first case in Europe.

Sara N Richter1, Ilaria Frasson, Cristina Bergo, Saverio Parisi, Antonietta Cavallaro, Giorgio Palù.   

Abstract

The first case in Europe of Klebsiella pneumoniae carbapenemase (KPC) 2 transfer from K. pneumoniae to Escherichia coli in the same patient is described. KPC-positive plasmids from the two species were identical, indicating horizontal plasmid transfer. Selection of the KPC-producing E. coli strain was triggered by therapy with meropenem.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21411573      PMCID： PMC3122676          DOI： 10.1128/JCM.00133-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  19 in total

1.  Escherichia coli producing KPC-2 carbapenemase: first report in Brazil.

Authors:  Ana Paula D'Alincourt Carvalho-Assef; Robson Souza Leão; Rosangela Vianna da Silva; Alex Guerra Ferreira; Liliane Miyuki Seki; Marise Dutra Asensi; Elizabeth Andrade Marques
Journal:  Diagn Microbiol Infect Dis       Date:  2010-09-17       Impact factor: 2.803

2.  Susceptibility profiles, molecular epidemiology, and detection of KPC-producing Escherichia coli isolates from the New York City vicinity.

Authors:  David Landman; Carl Urban; Martin Bäcker; Paul Kelly; Neha Shah; Elizabeth Babu; Simona Bratu; John Quale
Journal:  J Clin Microbiol       Date:  2010-10-06       Impact factor: 5.948

3.  Plasmid-mediated imipenem-hydrolyzing enzyme KPC-2 among multiple carbapenem-resistant Escherichia coli clones in Israel.

Authors:  Shiri Navon-Venezia; Inna Chmelnitsky; Azita Leavitt; Mitchell J Schwaber; David Schwartz; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

4.  Occurrence and characterization of carbapenemase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program (2000-2004).

Authors:  Lalitagauri M Deshpande; Ronald N Jones; Thomas R Fritsche; Helio S Sader
Journal:  Microb Drug Resist       Date:  2006       Impact factor: 3.431

Review 5.  Carbapenemases: the versatile beta-lactamases.

Authors:  Anne Marie Queenan; Karen Bush
Journal:  Clin Microbiol Rev       Date:  2007-07       Impact factor: 26.132

6.  Escherichia coli: development of carbapenem resistance during therapy.

Authors:  Tao Hong; Ellen Smith Moland; Baha Abdalhamid; Nancy D Hanson; Jie Wang; Cindy Sloan; Diane Fabian; Awny Farajallah; Jerome Levine; Kenneth S Thomson
Journal:  Clin Infect Dis       Date:  2005-04-13       Impact factor: 9.079

7.  High-level carbapenem resistance in a Klebsiella pneumoniae clinical isolate is due to the combination of bla(ACT-1) beta-lactamase production, porin OmpK35/36 insertional inactivation, and down-regulation of the phosphate transport porin phoe.

Authors:  Frank M Kaczmarek; Fadia Dib-Hajj; Wenchi Shang; Thomas D Gootz
Journal:  Antimicrob Agents Chemother       Date:  2006-10       Impact factor: 5.191

8.  Detection and spread of Escherichia coli possessing the plasmid-borne carbapenemase KPC-2 in Brooklyn, New York.

Authors:  Simona Bratu; Steven Brooks; Sibte Burney; Sandeep Kochar; Jyoti Gupta; David Landman; John Quale
Journal:  Clin Infect Dis       Date:  2007-02-21       Impact factor: 9.079

9.  Transfer of carbapenem-resistant plasmid from Klebsiella pneumoniae ST258 to Escherichia coli in patient.

Authors:  Moran G Goren; Yehuda Carmeli; Mitchell J Schwaber; Inna Chmelnitsky; Vered Schechner; Shiri Navon-Venezia
Journal:  Emerg Infect Dis       Date:  2010-06       Impact factor: 6.883

10.  mlstdbNet - distributed multi-locus sequence typing (MLST) databases.

Authors:  Keith A Jolley; Man-Suen Chan; Martin C J Maiden
Journal:  BMC Bioinformatics       Date:  2004-07-01       Impact factor: 3.169
View more
  10 in total

1.  Genomic epidemiology of Klebsiella pneumoniae in Italy and novel insights into the origin and global evolution of its resistance to carbapenem antibiotics.

Authors:  Stefano Gaiarsa; Francesco Comandatore; Paolo Gaibani; Marta Corbella; Claudia Dalla Valle; Sara Epis; Erika Scaltriti; Edoardo Carretto; Claudio Farina; Maria Labonia; Maria Paola Landini; Stefano Pongolini; Vittorio Sambri; Claudio Bandi; Piero Marone; Davide Sassera
Journal:  Antimicrob Agents Chemother       Date:  2014-11-03       Impact factor: 5.191

2.  A rapid matrix-assisted laser desorption ionization-time of flight mass spectrometry-based method for single-plasmid tracking in an outbreak of carbapenem-resistant Enterobacteriaceae.

Authors:  Anna F Lau; Honghui Wang; Rebecca A Weingarten; Steven K Drake; Anthony F Suffredini; Mark K Garfield; Yong Chen; Marjan Gucek; Jung-Ho Youn; Frida Stock; Hanna Tso; Jim DeLeo; James J Cimino; Karen M Frank; John P Dekker
Journal:  J Clin Microbiol       Date:  2014-05-21       Impact factor: 5.948

3.  Antimicrobial treatment and containment measures for an extremely drug-resistant Klebsiella pneumoniae ST101 isolate carrying pKPN101-IT, a novel fully sequenced bla(KPC-2) plasmid.

Authors:  Ilaria Frasson; Enrico Lavezzo; Elisa Franchin; Stefano Toppo; Luisa Barzon; Antonietta Cavallaro; Sara N Richter; Giorgio Palù
Journal:  J Clin Microbiol       Date:  2012-09-12       Impact factor: 5.948

4.  Features of infections due to Klebsiella pneumoniae carbapenemase-producing Escherichia coli: emergence of sequence type 131.

Authors:  Young Ah Kim; Zubair A Qureshi; Jennifer M Adams-Haduch; Yoon Soo Park; Kathleen A Shutt; Yohei Doi
Journal:  Clin Infect Dis       Date:  2012-04-04       Impact factor: 9.079

Review 5.  Treatment of Klebsiella pneumoniae carbapenemase (KPC) infections: a review of published case series and case reports.

Authors:  Grace C Lee; David S Burgess
Journal:  Ann Clin Microbiol Antimicrob       Date:  2012-12-13       Impact factor: 3.944

6.  Antimicrobial susceptibility testing in predicting the presence of carbapenemase genes in Enterobacteriaceae in South Africa.

Authors:  Ashika Singh-Moodley; Olga Perovic
Journal:  BMC Infect Dis       Date:  2016-10-04       Impact factor: 3.090

7.  Susceptibility of Colistin-Resistant, Gram-Negative Bacteria to Antimicrobial Peptides and Ceragenins.

Authors:  Marjan M Hashemi; John Rovig; Scott Weber; Brian Hilton; Mehdi M Forouzan; Paul B Savage
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

8.  Genomic characterization of NDM-1 and 5, and OXA-181 carbapenemases in uropathogenic Escherichia coli isolates from Riyadh, Saudi Arabia.

Authors:  Moataz Abd El Ghany; Hazem Sharaf; Mohamed H Al-Agamy; Atef Shibl; Grant A Hill-Cawthorne; Pei-Ying Hong
Journal:  PLoS One       Date:  2018-08-15       Impact factor: 3.240

9.  Defining the architecture of KPC-2 Carbapenemase: identifying allosteric networks to fight antibiotics resistance.

Authors:  Ioannis Galdadas; Silvia Lovera; Guillermo Pérez-Hernández; Melissa D Barnes; Jess Healy; Hamidreza Afsharikho; Neil Woodford; Robert A Bonomo; Francesco L Gervasio; Shozeb Haider
Journal:  Sci Rep       Date:  2018-08-27       Impact factor: 4.379

Review 10.  Global Dissemination of Carbapenemase-Producing Klebsiella pneumoniae: Epidemiology, Genetic Context, Treatment Options, and Detection Methods.

Authors:  Chang-Ro Lee; Jung Hun Lee; Kwang Seung Park; Young Bae Kim; Byeong Chul Jeong; Sang Hee Lee
Journal:  Front Microbiol       Date:  2016-06-13       Impact factor: 5.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.